Document Detail


Clinical and economic outcomes in patients switched to simvastatin in a community-based family medicine practice.
MedLine Citation:
PMID:  20653799     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The introduction of a generic formulation of simvastatin has created the potential to provide significant low-density lipoprotein cholesterol (LDL-C) reduction in a highly cost-effective manner.
METHODS: This retrospective cohort analysis utilised electronic medical record data from a United States, community-based, independent physician family medicine practice. Patients switched from other statins or statin combinations to simvastatin by the family medicine physicians during routine patient care from January 2002 to October 2008 were identified. Equivalent statin dosing, lipid panel changes and National Cholesterol Education Program--Adult Treatment Panel III (NCEP) LDL-C goal attainment rates were compared preswitch and postswitch. The potential economic impact of simvastatin switching was also evaluated.
RESULTS: A total of 78 patients were identified, and in 76.9% of the switches, an equipotent dose of simvastatin was prescribed. All lipid fractions showed small, non-significant increases, with LDL-C having a 2.2 mg/dl (0.06 mmol/l) increase after switching (p = 0.476). NCEP LDL-C goal attainment rates were 79.5% and 78.2% before and after switching, respectively (p = 1.00). Modelled annual cost savings associated with switching were estimated at $671.99 per patient.
CONCLUSIONS: These results demonstrate that an independent family medicine physician practice can successfully perform statin therapeutic substitution during routine patient care. Equivalent clinical outcomes with regards to changes in lipid fractions and NCEP LDL-C goal attainment were observed in conjunction with the potential for reduced costs for patients.
Authors:
V J Willey; J A Reinhold; K H Willey; B L Kelly; M J Cziraky
Related Documents :
19887949 - Behaviour modification and benign prostatic hyperplasia: replacement for medications.
17592539 - Management of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome who h...
19966739 - Airway management of an elective surgical patient.
22920029 - Maintain workplace civility by sharing the vow of personal responsibility.
20436839 - Catecholamine-secreting paragangliomas: recent progress in diagnosis and perioperative ...
2231899 - The management of posterior urethral valves by initial vesicostomy and delayed valve ab...
22666149 - Personal construction of cough medicine among young substance abusers in hong kong.
20223409 - Computed tomography-guided pericardiocentesis: utility in the management of malignant p...
8563319 - Reasons for the loss of sensitivity and specificity of methodologic mesh terms and text...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of clinical practice     Volume:  64     ISSN:  1742-1241     ISO Abbreviation:  Int. J. Clin. Pract.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-26     Completed Date:  2011-08-01     Revised Date:  2011-12-27    
Medline Journal Info:
Nlm Unique ID:  9712381     Medline TA:  Int J Clin Pract     Country:  England    
Other Details:
Languages:  eng     Pagination:  1235-8     Citation Subset:  IM    
Affiliation:
Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA 19104, USA. v.willey@usp.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anticholesteremic Agents / economics,  therapeutic use*
Cholesterol, LDL / blood
Cost Savings
Cost-Benefit Analysis
Drug Substitution / economics*
Drugs, Generic / economics,  therapeutic use*
Family Practice / economics
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics,  therapeutic use*
Hypercholesterolemia / drug therapy*,  economics
Male
Middle Aged
Retrospective Studies
Simvastatin / economics,  therapeutic use*
Chemical
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Cholesterol, LDL; 0/Drugs, Generic; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 79902-63-9/Simvastatin
Comments/Corrections
Comment In:
Int J Clin Pract. 2011 Dec;65(12):1321-2   [PMID:  22093540 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination th...
Next Document:  Normal coronary angiography and primary percutaneous coronary intervention for ST elevation myocardi...